{"hands_on_practices": [{"introduction": "Defining a cell as pluripotent is a significant claim that requires rigorous proof beyond simple observation or marker expression. The gold-standard method for this is the teratoma assay, a functional test that directly assesses a cell's developmental potential in vivo. This exercise challenges you to interpret the results of this critical assay to confirm whether a cell line can truly give rise to tissues from all three embryonic germ layers: ectoderm, mesoderm, and endoderm. [@problem_id:2338709]", "problem": "A cell biologist has successfully isolated and cultured a novel cell line from a tissue sample and hypothesizes that these cells are pluripotent. Pluripotency is the developmental potential of a single cell to differentiate into cell types derived from all three primary embryonic germ layers. These layers are the ectoderm (which gives rise to skin and the nervous system), the mesoderm (which forms muscle, bone, and blood), and the endoderm (which forms the lining of the digestive and respiratory tracts).\n\nTo functionally test this hypothesis, the researcher performs the definitive assay for pluripotency. They inject a sample of the cultured cells subcutaneously into an immunodeficient mouse. After several weeks, a palpable, tumor-like growth develops at the site of injection. The researcher excises this growth and sends it for histological analysis, which involves the microscopic examination of stained tissue sections.\n\nWhich of the following findings from the histological analysis would provide the conclusive evidence needed to classify the original cell line as pluripotent?\n\nA. The growth is a benign tumor containing a chaotic mixture of differentiated tissues, including neural rosettes (ectoderm), cartilage (mesoderm), and glandular structures resembling gut epithelium (endoderm).\n\nB. The growth is a malignant, rapidly-proliferating mass composed entirely of undifferentiated cells that are morphologically identical to the original injected cells.\n\nC. The growth consists exclusively of a single, well-organized tissue type, such as a large mass of striated muscle fibers (mesoderm).\n\nD. The growth is heavily infiltrated by the mouse's immune cells, such as T-cells and macrophages, indicating a strong inflammatory response to the foreign cells.\n\nE. The injected cells are found to have migrated from the injection site and integrated seamlessly into the mouse's existing organs, such as the liver and spleen, without forming any distinct tumorous growth.", "solution": "The stated hypothesis is that the novel cell line is pluripotent. By definition, pluripotency is the capacity of a single cell to differentiate into cell types derived from all three primary embryonic germ layers: ectoderm, mesoderm, and endoderm. The definitive functional assay for pluripotency in mammals is the teratoma formation assay, in which candidate cells are injected into an immunodeficient mouse; pluripotent cells form a teratoma, a benign tumor containing differentiated tissues representative of all three germ layers. Histological confirmation of tri-lineage differentiation within the teratoma is required for conclusive evidence.\n\nEvaluating the options in light of this principle:\n- Option A describes a benign tumor containing a mixture of differentiated tissues explicitly representing ectoderm (neural rosettes), mesoderm (cartilage), and endoderm (glandular gut-like epithelium). This is the canonical histological profile of a teratoma and provides conclusive evidence of pluripotency.\n- Option B describes a malignant, undifferentiated mass, which indicates proliferation or tumorigenicity but does not demonstrate differentiation, let alone tri-lineage differentiation; it does not prove pluripotency.\n- Option C shows differentiation into a single tissue type (mesodermal), which could reflect multipotency or lineage bias, but not pluripotency.\n- Option D reflects an immune response, which is not a criterion for pluripotency and is expected to be minimized in immunodeficient mice used for this assay.\n- Option E describes migration and integration without teratoma formation; while integration can be a feature in other assays (e.g., chimera formation), it does not constitute the definitive teratoma assay evidence of tri-lineage differentiation.\n\nTherefore, only Option A matches the definitive histological evidence for pluripotency.", "answer": "$$\\boxed{A}$$", "id": "2338709"}, {"introduction": "While pluripotent stem cells can form any tissue, most adult stem cells are lineage-restricted, tasked with regenerating specific tissues. To confirm the identity of an adult stem cell, such as a muscle satellite cell, a different kind of functional assay is neededâ€”one that specifically tests its ability to differentiate into the correct mature cell type. This practice asks you to design the most definitive in vitro experiment to prove that a population of isolated cells are indeed functional muscle stem cells. [@problem_id:2338730]", "problem": "A cell biology researcher is working on skeletal muscle regeneration. After enzymatic digestion of a muscle biopsy, the researcher isolates a population of mononuclear cells that adhere to culture dishes. They hypothesize that these cells are satellite cells, which are the resident adult stem cells of skeletal muscle. To support this claim, the researcher needs to perform a functional assay. Which of the following experimental plans provides the most direct and definitive *in vitro* evidence that the isolated cells are indeed functional muscle stem cells capable of myogenesis?\n\nA. Culture the cells in specific media designed to induce differentiation into neurons (ectoderm), osteoblasts (mesoderm), and pancreatic cells (endoderm), and check for the expression of lineage-specific markers for all three germ layers.\n\nB. Culture the cells in a high-serum growth medium for 72 hours and quantify their rate of proliferation by measuring the incorporation of 5-ethynyl-2'-deoxyuridine (EdU).\n\nC. Culture the cells to confluence in a high-serum growth medium and then switch them to a low-serum differentiation medium for several days. Subsequently, fix the cells and use immunofluorescence to detect the presence of multinucleated myotubes expressing myosin heavy chain.\n\nD. Immediately after isolation, lyse the cells to extract messenger RNA (mRNA). Then, perform reverse transcription quantitative Polymerase Chain Reaction (RT-qPCR) to measure the expression level of the transcription factor Pax7, a known marker for satellite cells.", "solution": "We begin by identifying the functional property to be demonstrated. Satellite cells are the resident adult stem cells of skeletal muscle and are lineage-restricted myogenic progenitors. The functional hallmark relevant to this question is their capacity for myogenesis in vitro: upon appropriate cues, they exit proliferation, express muscle-specific differentiation markers, and fuse to form multinucleated myotubes.\n\nTo design a definitive in vitro functional assay, the experimental plan should directly test myogenic differentiation and fusion. In standard myogenesis protocols, satellite cells or myoblasts are expanded in high-serum growth medium to proliferate, then switched to low-serum differentiation medium to induce terminal differentiation and fusion. Successful myogenesis is evidenced by the appearance of multinucleated myotubes expressing late muscle differentiation markers such as myosin heavy chain.\n\nWe now evaluate the options in terms of whether they constitute direct and definitive in vitro evidence of functional myogenic potential:\n- Option A tests tri-lineage differentiation into ectodermal, mesodermal, and endodermal derivatives. This is a pluripotency assay appropriate for embryonic stem cells or induced pluripotent stem cells. Satellite cells are adult, lineage-restricted stem cells; they are not expected to generate all three germ layers. Thus, Option A is not relevant and does not directly assess myogenic function.\n- Option B measures proliferation via EdU incorporation. While proliferation is a property of activated satellite cells and myoblasts, it is neither specific to stemness nor to myogenic identity. Many cell types proliferate in high-serum conditions. This does not demonstrate myogenesis.\n- Option C applies the canonical in vitro myogenic differentiation paradigm: expand to confluence in high-serum growth medium, switch to low-serum differentiation medium, then assay for multinucleated myotubes expressing myosin heavy chain by immunofluorescence. The formation of multinucleated myotubes and expression of myosin heavy chain are direct and definitive indicators of successful myogenic differentiation and fusion, thereby providing functional evidence of myogenesis.\n- Option D measures Pax7 mRNA immediately after isolation. Pax7 is a well-established marker of quiescent and early activated satellite cells, but marker expression alone is not a functional assay and does not establish differentiation capacity. It is supportive but not definitive for functional stem cell identity.\n\nTherefore, the most direct and definitive in vitro evidence that the isolated cells are functional muscle stem cells capable of myogenesis is to induce differentiation and demonstrate formation of multinucleated myotubes expressing myosin heavy chain, as described in Option C.", "answer": "$$\\boxed{C}$$", "id": "2338730"}, {"introduction": "Beyond identification, understanding the unique biological properties of stem cells is crucial for both basic research and therapeutic application. It is hypothesized that pluripotent stem cells rely heavily on glycolysis to minimize DNA-damaging reactive oxygen species produced during mitochondrial respiration. This hands-on data analysis problem allows you to test this hypothesis by interpreting metabolic flux data and calculating the contribution of glycolysis to the cell's energy budget. [@problem_id:2338713]", "problem": "Pluripotent stem cells, such as human Embryonic Stem Cells (ESCs), possess a unique metabolic profile often compared to the Warburg effect seen in cancer cells. It is hypothesized that these cells preferentially utilize glycolysis over mitochondrial oxidative phosphorylation (OXPHOS) for energy production. This strategy is thought to minimize the generation of Reactive Oxygen Species (ROS), which are byproducts of OXPHOS and can cause DNA damage, thereby protecting the genomic integrity crucial for pluripotency.\n\nTo investigate this hypothesis, a researcher performs a metabolic flux analysis on a culture of human ESCs. The experiment measures two key parameters: the Oxygen Consumption Rate (OCR), which is a measure of OXPHOS, and the Extracellular Acidification Rate (ECAR), which is a proxy for the rate of glycolysis (due to lactic acid secretion). The following baseline and inhibitor-treated measurements are obtained for the ESC culture, all normalized per unit of cell number:\n\n**Experimental Data:**\n- Basal OCR: $60.0$ pmol O$_{2}$/min\n- Basal ECAR: $250.0$ mpH/min\n- OCR after treatment with oligomycin (an ATP synthase inhibitor): $20.0$ pmol O$_{2}$/min\n- ECAR after treatment with 2-deoxy-D-glucose (2-DG, a competitive inhibitor of hexokinase): $25.0$ mpH/min\n\n**Conversion Factors for ATP Production Rate:**\n1.  The rate of ATP production from glycolysis, in units of pmol ATP/min, is numerically equal to the glycolytic portion of the ECAR. The glycolytic ECAR is defined as the basal ECAR minus the ECAR remaining after inhibition by 2-DG.\n2.  The ATP production from OXPHOS is directly proportional to the OCR that is coupled to ATP synthesis. This \"ATP-linked OCR\" is the basal OCR minus the OCR remaining after inhibition by oligomycin. Each pmol/min of ATP-linked OCR generates $5.5$ pmol/min of ATP.\n\nUsing the provided data and conversion factors, calculate the fraction of the total basal ATP production that originates from glycolysis in these ESCs. Report your answer as a decimal rounded to three significant figures.", "solution": "We are asked for the fraction of total basal ATP production that originates from glycolysis, using the given conversion rules.\n\nBy definition in the problem, the glycolytic ECAR is the basal ECAR minus the ECAR after inhibition by 2-DG. Therefore,\n$$\n\\text{glycolytic ECAR} = 250.0 - 25.0 = 225.0.\n$$\nBy the provided conversion factor, the ATP production rate from glycolysis (in pmol ATP/min) equals the glycolytic ECAR numerically:\n$$\n\\text{ATP}_{\\text{gly}} = 225.0.\n$$\n\nThe ATP-linked OCR is the basal OCR minus the OCR after oligomycin:\n$$\n\\text{ATP-linked OCR} = 60.0 - 20.0 = 40.0.\n$$\nUsing the given factor of $5.5$ pmol ATP per pmol ATP-linked OCR, the ATP production rate from OXPHOS is\n$$\n\\text{ATP}_{\\text{OXPHOS}} = 5.5 \\times 40.0 = 220.0.\n$$\n\nThe total basal ATP production rate is the sum of glycolytic and OXPHOS contributions:\n$$\n\\text{ATP}_{\\text{total}} = \\text{ATP}_{\\text{gly}} + \\text{ATP}_{\\text{OXPHOS}} = 225.0 + 220.0 = 445.0.\n$$\n\nThus, the fraction of total basal ATP production originating from glycolysis is\n$$\nf_{\\text{gly}} = \\frac{\\text{ATP}_{\\text{gly}}}{\\text{ATP}_{\\text{total}}} = \\frac{225.0}{445.0} = \\frac{45}{89} \\approx 0.505617977\\ldots\n$$\nRounded to three significant figures, this is\n$$\n0.506.\n$$", "answer": "$$\\boxed{0.506}$$", "id": "2338713"}]}